ArticleInternational journal of environmental research and public health2021

CD19 Cell Count at Baseline Predicts B Cell Repopulation at 6 and 12 Months in Multiple Sclerosis Patients Treated with Ocrelizumab.

Gianmarco Abbadessa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.